Teva UK Limited launches Olanzapine range
7 October 2011 | By Teva UK Ltd
Teva UK Ltd announce the off-patent launch of generic Olanzapine Teva Film-Coated Tablets & Olanzapine Teva Orodispersible Tablets...
List view / Grid view
News
FDA approves Merck’s JUVISYNC™ (sitagliptin and simvastatin) tablets
7 October 2011 | By Merck
Multiple national guidelines recommend that patients with type 2 diabetes be treated for cholesterol...
Tecan takes annual scientific symposium to Shanghai
6 October 2011 | By kdm communications
This year’s Tecan Symposium will be held in Shanghai, China, from the 2nd to 4th of November...
Merck announces retirement of Chairman and former CEO Richard T. Clark
6 October 2011 | By Merck
Merck announced that Richard T. Clark, chairman, will retire 1st December ...
FDA accepts New Drug Application filing for ridaforolimus, investigational mTOR inhibitor
5 October 2011 | By Merck
The FDA accepted for filing and review the New Drug Application for ridaforolimus...
Gilead and Boehringer Ingelheim sign license agreement for novel HIV non-catalytic integrase inhibitors
5 October 2011 | By Gilead Sciences
Gilead Sciences, Inc. and Boehringer Ingelheim have entered into a licensing agreement...
Lundbeck appoints three Vice Presidents in Supply Operations & Engineering
5 October 2011 | By H. Lundbeck A/S
Lundbeck has appointed Kristian Sibilitz, Christian Houborg and Lene Andersen as Vice Presidents in Supply Operations & Engineering...
AstraZeneca enters into a settlement agreement with Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd regarding US SEROQUEL XR® patent litigation
5 October 2011 | By Astrazeneca
AstraZeneca enters into a settlement agreement with Accord Healthcare, Inc. & Intas Pharmaceuticals Ltd...
BRILIQUE receives a positive preliminary medical benefit assessment for the majority of ACS patients in Germany as part of new AMNOG review process
4 October 2011 | By AstraZeneca
Report published on BRILIQUE (ticagrelor)...
Abbott enrolls first U.S. patient in global EXCEL trial
4 October 2011 | By Abbott
Abbott's EXCEL is the largest trial to date designed to evaluate optimal treatment strategy in patients with unprotected left main disease...
Pfizer launches new BeneFIX® room temperature storage packs for haemophilia B in Europe
3 October 2011 | By Ogilvy Healthworld UK Limited
Pfizer announce the launch of BeneFIX® with Room Temperature Storage (RTS)....
B&W Tek introduces next generation handheld Raman instrument for material verification in cGMP compliant facilities
3 October 2011 | By B&W Tek
B&W Tek, Inc., is proud to introduce the NanoRam™...
Takeda receives positive CHMP opinion in Europe for EdarbiTM (azilsartan medoxomil)
29 September 2011 | By Takeda Pharmaceutical Company Limited
The CHMP has issued a positive opinion for EdarbiTM (azilsartan medoxomil)...
Tecan’s new MCA 384 Disposable Tips offer enhanced pipetting flexibility
27 September 2011 | By kdm communications limited
Tecan has launched a new generation of high quality MCA 384 Disposable Tips...
BIBF 1120* in patients with metastatic colorectal cancer as effective as bevacizumab with less serious adverse events
27 September 2011 | By Boehringer Ingelheim
Results from a Phase I/II study...
